Synthesis and Antifungal Properties of Some Benzimidazole Derivatives
Some benzimidazole derivatives were synthesized and their in vitro antifungal activities were tested against Candida albicans, Candida glabrata and Candida krusei. Compounds 6 and 9 possessed activity comparable to fluconazole against C. albicans with a minimum inhibitory concentration of 12.5 m g/mL.
Synthesis and Antifungal Properties of Some Benzimidazole Derivatives
Some benzimidazole derivatives were synthesized and their in vitro antifungal activities were tested against Candida albicans, Candida glabrata and Candida krusei. Compounds 6 and 9 possessed activity comparable to fluconazole against C. albicans with a minimum inhibitory concentration of 12.5 m g/mL.
___
- V.L. Khairnar, S.R. Lockhande, M.R. Patel and B.G. Khadse, Chemical Abstract 95, 203833h (1981).
- L.L. Kruse, D.L. Ladd, P.B. Harrsch, F.L. McCabe, S.M. Mong, L. Faucette and R. Johnson, J. Med. Chem. , 409-417 (1989).
- I. Islam, E.B. Skibo, R.T. Dorr and D.S. Alberts, J. Med. Chem. 34, 2954-2961 (1991).
- V.J. Habernickel, Drugs made in Germany, 35, 97 (1992).
- T. Fukuda, T. Saito, S. Tajima, K. Shimohara and K. Ito, Arzneim.-Forsch./Drug Res. 34, 805-810 (1984).
- H. Nakano, T. Inoue, N. Kawasaki, H. Miyataka, H. Matsumoto, T. Taguchi, N. Inagaki, H. Nagai and T. Satoh, Chem. Pharm. Bull. 47, 1573-1578 (1999).
- B. Can-Eke, M.O. Puskullu, E. Buyukbingol and M. ˙I¸scan, Chemico-Biological Interactions 113, 65-77 (1998).
- C. Ku¸s, G. Ayhan-Kılcıgil, B. Can-Eke and M. ˙I¸scan, Arch. Pharm. Res. 27, 156-163 (2004).
- G. Ayhan-Kılcıgil, C. Ku¸s, T. C¸ oban, B. Can-Eke and M. ˙I¸scan, Journal of Enzyme Inhibition and Medicinal Chemistry 19, 129-135 (2004).
- H. G¨oker, G. Ayhan-Kılcıgil, M. Tun¸cbilek, C. Ku¸s, R. Ertan, E. Kendi, S. ¨Ozbey, M. Fort, C. Garcia and A.J. Farre, Heterocycles 51, 2561-2573 (1999).
- A.E. Abdel-Rahman, A.M. Mahmoud, G.M. El-Naggar and H.A. El-Sherief, Pharmazie 38, 589-590 (1983).
- F.S.G. Soliman, S.M. Rida, E.A.M. Badawey and T. Kappe, Arch. Pharm. 317, 951-958 (1984).
- R.A. Coburn, M.T. Clark, R.T. Evans and R.J. Genco, J. Med. Chem. 30, 205-208(1987).
- N.S. Habib, S. Abdel-Hamid and M. El-Hawash, Farmaco, 44, 1225-1232 (1989).
- H. G¨oker, C. Ku¸s, D.W. Boykin, S. Yıldız and N. Altanlar, Bioorg. Med. Chem. 10, 2589-2596 (2002).
- S. ¨Ozden, H. Karata¸s, S. Yıldız and H. Goker, Arch. Pharm. Pharm. Med. Chem. 337, 556-562 (2004).
- S. ¨Ozden, D. Atabey, S.Yıldız and H. G¨oker, Bioorg. Med. Chem. 13, 1587-1597 (2005).
- I. K¨u¸c¨ukg¨uzel, G. K¨u¸c¨ukg¨uzel, S. Rollas and M. Kiraz, Bioorg. Med. Chem. Letters 11, 1703-7007 (2001).
- M.S. El-Gaby, J.A. Micky, N.M. Taha and M.A.M. El-Sharief, J. Chin. Chem. Soc. 49, 407-414 (2002).
- C. Ku¸s, H. G¨oker, G. Ayhan, R. Ertan, N. Altanlar and A. Akın, Il Farmaco 51, 413-417 (1996).
- H. G¨oker, M. Tun¸cbilek, G. Ayhan and N. Altanlar, Il Farmaco 53, 415-420 (1998).
- G. Ayhan-Kılcıgil, M. Tun¸cbilek, N. Altanlar and H. G¨oker, Il Farmaco 54, 562-565 (1999).
- G. Ayhan-Kılcıgil and N. Altanlar, Il Farmaco 58, 1345-1350 (2003).
- H. Willitzer, D. Brauniger, D. Engelmann, D. Krebs, W. Ozegowski and M. Tonew, Pharmazie 33, 30-38 (1978).
- H.F. Ridley, R.G.W. Spickett and G.M.J. Timmis, Heterocyclic Chem. 2, 453-456 (1965).
- D.F. Sahm and J.A. Washington, “Antibacterial Susceptibility Tests: Dilution Methods”, in Manual of Clinical Microbiology, 5thed., eds. A. Balowes, W.J. Hausler, K.L. Hermann and H.D. Shadomy, pp. 1105-1116,
- American Society for Microbiology, Washington DC, 1991.